top
Search terms
Results 1 - 10 of 53 - ordered by :
Pages: 1 2 3 4 5 6 ... 6
Ehjcvp

Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of ...

European Heart Journal - Cardiovascular Pharmacotherapy, Corrigendum

Date : 14/07/2016 Item size : 90286 bytes
Ehjcvp

Effect of rapid desensitization on platelet inhibition and basophil activation in patients with aspirin hypersensitivity and coronary disease Cases were patients with coronary artery disease (CAD) ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Article, Stéphane Manzo-Silberman, Pascale Nicaise-Roland, Catherine Neukirch, Florence Tubach, Marie-Geneviève Huisse, Sylvie ...

Date : 05/08/2016 Item size : 209243 bytes
Ehjcvp

Mechanistically, this separates the drug from conventional anti-anginal therapies, namely beta-adrenergic antagonists, calcium channel blockers, and nitrates. [...]a haemodynamically neutral ...

European Heart Journal - Cardiovascular Pharmacotherapy, Reviews, Cian P. McCarthy, Kieran V. Mullins, David M. Kerins

Date : 01/10/2016 Item size : 282882 bytes
Ehjcvp

[...]our presence in MEDLINE will increase the visibility of, and interest for, the journal. [...]the editors and editorial board members feel very satisfied and confident for the future of the ...

European Heart Journal - Cardiovascular Pharmacotherapy, Editorials, Stefan Agewall

Date : 01/10/2016 Item size : 112617 bytes
Ehjcvp

Introduction Dual antiplatelet therapy (DAPT), consisting of the combination of aspirin and a P2Y12 inhibitor, is recommended by guidelines for up to 12 months in patients with acute coronary ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Articles, Gianluigi Savarese, Stefano Savonitto, Lars H. Lund, Stefania Paolillo, Caterina Marciano, Santo Dellegrottaglie, Antonio ...

Date : 01/10/2016 Item size : 333679 bytes
Ehjcvp

Atrial fibrillationIschaemic strokePreventionOral anticoagulationIntroduction Atrial fibrillation (AF) is an expanding epidemic,1 and ischaemic stroke due to cardioembolism remains a trademark ...

European Heart Journal - Cardiovascular Pharmacotherapy, Current Opinion, Thure Filskov Overvad, Peter Brønnum Nielsen, Gregory Y. H. Lip

Date : 12/08/2016 Item size : 256208 bytes
Ehjcvp

In this issue of the journal, Serebruany and co-workers report data from a study of clinical utilization of dual antiplatelet therapy (DAPT) in patients with renal impairment following percutaneous ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Stefan Agewall

Date : 01/07/2016 Item size : 96542 bytes
Ehjcvp

Variability of low-density lipoprotein cholesterol response with different doses of atorvastatin, rosuvastatin, and simvastatin: results from VOYAGER The aim of this study was to use individual ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Articles, Björn W. Karlson, Olov Wiklund, Michael K. Palmer, Stephen J. Nicholls, Pia Lundman, Philip J. Barter

Date : 01/10/2016 Item size : 168264 bytes
Ehjcvp

Optimal handling of the healthy In the preventive section, the HOPE-3 (Heart Outcomes Prevention Evaluation 3) trial stole the limelight, first and foremost by strengthening faith in statinsthis time ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Manan Pareek, Deepak L. Bhatt

Date : 01/07/2016 Item size : 164372 bytes
Ehjcvp

[...]SGLT2 inhibition represents a novel treatment, which might be a promising target not only to (further) reduce blood glucose but also to target other cardiovascular risk factors. SGLT2 ...

European Heart Journal - Cardiovascular Pharmacotherapy, Review, Anne E. de Leeuw, Rudolf A. de Boer

Date : 01/10/2016 Item size : 586778 bytes